Description: Aboca LibraMed 138 Tablets is a food supplement that controls blood glucose peaks reducing the accumulation of fats and sensation of hunger. It is recommended for the treatment of overweight, obesity, and to reduce the circumference of the belly. Clinically tested, this medical device acts thanks to a patented complex of polysaccharidic macromolecules, the Policaptil Gel Retard. Policaptil provokes the formation of a gel in the intestine that acts on the glucids reducing the quality absorbed and the speed of absorption. Thanks to the properties of this gel, it also enhances the transit and regulates the consistency of excrements. Results:After 30 days of treatment, we notice a reduction of 1,3kg with a maximum of 5kg. After 60 days of treatment, we notice a reduction of 1,8kg with a maximum of 10kg. After 30 days of treatment, we notice a reduction of 2,9cm of the belly circumference. After 60 days of treatment, we notice a reduction of 4,5cm of the belly circumference. Indications: To treat overweight, obesity, to reduce the belly circumference. Composition: Patented complex of polysaccharide macromolecules (Policaptil Gel Retard), Aromas of Orange, Apple and Lemon. Policaptil Gel Retard is a patented macromolecular complex resulting from Aboca research, carried out by means of a production technology that allows to concentrate polysaccharide fractions obtained from: Cellulose, Opuntia Ficus Indica, Amorphophallus Konjac, Althaea Officinalis, Linus Ussitatissimum, Tilia Platyphyllos, Cichorium Intybus. Directions: Children over 12 years old: 3 tablets before the 2 main meals. Children between 8 and 12 years old: take 2 tablets before the 2 main meals. To take with a large glass of water. To take during at least 2 months, suspending the treatment 2-3 days after each treatment. If you are diabetic, ask for the advice of your doctor. Not advised for pregnant or breastfeeding women. Details: EAN/UPC: 8032472010821 Contents: 138 Tablets Presentation: Bottle
